Merdad Parsey - Dec 10, 2023 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role: Chief Medical Officer
Signature: /s/ Edward S. Son by Power of Attorney for Merdad Parsey
Stock symbol: GILD
Transactions as of: Dec 10, 2023
Transactions value $: -$100,276
Form type: 4
Date filed: 12/11/2023, 07:10 PM
Previous filing: Sep 13, 2023
Next filing: Feb 2, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GILD	Common Stock	Options Exercise		+2.78K	+3.96%		72.9K	Dec 10, 2023	Direct	F1
transaction	GILD	Common Stock	Tax liability	-$100K	-1.27K	-1.74%	$79.02	71.6K	Dec 10, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GILD	Restricted Stock Unit	Options Exercise		-2.78K	-6.35%		41K	Dec 10, 2023	Common Stock	2.78K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2	The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.